The document, titled "Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard—Third Edition," is a proprietary standard published by the Clinical and Laboratory Standards Institute (CLSI) .
The standard incorporated findings from College of American Pathologists (CAP) surveys, leading to the exemption of 27 additional media types compared to its predecessor (M22-A2). Performance Criteria: It sets a maximum acceptable failure rate of is less than or equal to
By following these recommendations, you can ensure that you are providing accurate and reliable antimicrobial susceptibility testing results, which are critical for guiding patient care and controlling the spread of infectious diseases.